Novavax Announces Participation in Key Investor Conferences
![Novavax Announces Participation in Key Investor Conferences](https://investorshangout.com/images/blog/ihnews-Novavax%20Announces%20Participation%20in%20Key%20Investor%20Conferences.jpg)
Novavax Engages in Upcoming Investor Conferences
Novavax, Inc. (Nasdaq: NVAX), a global leader in advancing innovative protein-based vaccines, recently made headlines by announcing its participation in two key investor conferences this month. The company is recognized for its novel Matrix-M™ adjuvant, which enhances the immune response to vaccines.
H.C. Wainwright 26th Annual Global Investment Conference
As part of its engagement strategy, Novavax will feature in the H.C. Wainwright 26th Annual Global Investment Conference. This event will take place on Monday, September 9, 2024, where the company will conduct a fireside chat between 3:30 PM to 4:00 PM Eastern Time. Vernon Bernardino, Managing Director and Senior Healthcare Analyst, will moderate this session. Key participants from Novavax include Jim Kelly, Executive Vice President, Chief Financial Officer, and Treasurer, along with Robert Walker, MD, Senior Vice President and Chief Medical Officer.
Conference Details
The fireside chat will enable investors to gain insights into Novavax's strategy and future initiatives. The session provides a platform for discussing the company’s efforts to enhance vaccine development technologies.
Baird 2024 Global Healthcare Conference
The second significant event Novavax will attend is the Baird 2024 Global Healthcare Conference on Tuesday, September 10, 2024. The company will give a presentation from 3:10 PM to 3:40 PM ET, aiming to bring attention to its innovative vaccine pipeline and ongoing research initiatives. This conference will also occur in New York City, enhancing networking opportunities amongst industry leaders and investors.
Event Participation
At both conferences, Novavax will reiterate its commitment to developing impactful healthcare solutions. The participation of top executives reinforces the company’s dedication to sharing its vision and progress with stakeholders.
Replay and Additional Information
A replay of both the fireside session and the presentation will be accessible on the Events and Presentations page of Novavax's website, ensuring that those who cannot attend can still benefit from the discussions for 30 days following the conferences.
About Novavax
Novavax, Inc. (Nasdaq: NVAX) is dedicated to discovering, developing, and commercializing innovative vaccines that protect against serious infectious diseases. The company utilizes a unique vaccine platform that integrates recombinant protein technologies and advanced nanoparticle solutions alongside its proprietary Matrix-M adjuvant. Currently, Novavax boasts an extensive portfolio, including its COVID-19 vaccine and ongoing candidates aimed at COVID-19-Influenza combination and standalone influenza therapies. Notably, Novavax’s Matrix-M adjuvant is instrumental in the University of Oxford and Serum Institute of India's malaria vaccine.
Contact Information
Investors:
Erika Schultz
240-268-2022
[email protected]
Media:
Giovanna Chandler
202-709-5563
[email protected]
Frequently Asked Questions
What is Novavax's primary focus in the healthcare sector?
Novavax focuses on developing innovative vaccines to combat serious infectious diseases through its unique protein-based technology.
When is Novavax participating in investor conferences?
Novavax is participating in two investor conferences on September 9 and 10, 2024.
Who are the key participants from Novavax at the conferences?
Key participants include Jim Kelly, Executive Vice President and CFO, and Robert Walker, MD, Senior Vice President and CMO.
What platform does Novavax utilize for its vaccine development?
Novavax employs a recombinant protein approach combined with advanced nanoparticle technology and the Matrix-M adjuvant.
Where can I find the replay of the Novavax conference presentations?
The replay will be available on Novavax's Events and Presentations page for 30 days post-conference.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- Felo AI Launch: Transforming Search with Language Innovation
- ASLA Unveils Transformative 2024 Professional Awards Winners
- Growth of the Packaging Automation Market Towards 2032
- Chemical Injection Pumps Market Growth Expected at 8.4% CAGR
- Projected Growth of Conductive Polymer Coating Market
- Earn Alliance Appoints Jeff Drobick as New COO to Enhance Growth
- Court TV Announces Exciting Fall Primetime Lineup for 2024
- Endeavour Mining Updates on Major Shareholder Notification
- Vishay Intertechnology Expands Haptic Feedback Actuators Range
- Moon Gaming Inc. Unveils Moon Poker: Exciting Tournaments Ahead
- J.P. Morgan Enhances Morgan Money with Kyriba Integration
- Exploring the Impact of the 2016 Election Docuseries
- MALK Organics Launches Almond Pumpkin Spice for Fall 2024
- Explore Local Wines with KSL Resorts' Exciting Package
- Accorto Regulatory Solutions Partners with GINN for Tobacco Safety
- Carterra Ultra™: Transforming Drug Discovery with Precision
- Attain Capital Welcomes Former NASA CIO Renee P. Wynn
- Aiga Capital Partners Launches $240 Million Sustainable Fund
- ICEYE and Aon Join Forces to Boost Flood and Wildfire Response
- Laurence Moroney to Speak at Info-Tech LIVE 2024 Conference
- Philadelphia Fed Initiates Search for New President Following Harker
- Israel Stock Exchange Overview: TA 35 Declines Amid Sectors
- Oslo Stock Exchange Sees Subtle Gains, Led by Healthcare
- Why Freeport-McMoRan Is a Superior Investment Choice Today
- Understanding Retirement with $600,000: Ways to Plan Ahead
Recent Articles
- Carterra Ultra™: Transforming Drug Discovery with Precision
- Aiga Capital Partners Launches $240 Million Sustainable Fund
- Unilever Secures Approval to Sell Russian Assets Amid Criticism
- Growth Prospects for Global Furniture Fittings Market Ahead
- US Job Openings Hit 3.5-Year Low: Labor Market Overview
- Norfolk Southern Secures Tentative Agreement with Conductors' Union
- Davidson Kempner Discloses Stake in International Paper Co.
- Kontakt.io Revolutionizes Asset Tracking with Sticker Tag
- Binswanger Welcomes Brooke Oldt as Senior VP of Corporate Services
- TrustGrid Partners with Department of Air Force for Innovation
- U.S. Steel Alerts on Job Risks Amid Nippon Merger Concerns
- Data Center Networking Sector Set for USD 76.87 Billion Growth
- Sports Betting Market Growth Expected to Reach $221.4 Billion
- Material Handling Equipment Market Growth Driven by Innovation
- Tenable Unveils Enhanced Nessus for Effective Risk Management
- AmpliTech Group Showcases 5G Solutions at MWC Events
- Bright Mountain Media Welcomes Elaine Riddell to the Board
- ORBIS Production Recognized as Top Video Production Company
- LIXTE Secures U.S. Patent for Innovative Cancer Treatments
- Fossil Group Welcomes Franco Fogliato as New CEO
- Worlds Inc. Uplists to OTCQB, Enhancing Market Presence and Value
- Lumafield Launches Advanced Battery Analysis Module for Quality
- 60 Degrees Pharmaceuticals Secures $4 Million Through Placement
- EPAM to Expand Capabilities with NEORIS Acquisition Deal
- J.Jill Reports Strong Q2 Earnings but Cautious on Q3 Outlook